Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_
Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_ Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_
Poster Topic: Tumours Abstract number: 24435 EN BLOC RESCTION OF OSTEOSARCOMA OF PROXIMAL FIBULA: AN ANALYSIS OF 8 CASES Kamal BALI, Raghav SAINI, Mandeep DHILLON PGIMER, Chandigarh (INDIA) Background and purposeOsteosarcoma of proximal fibula is a rare entity that poses a great surgical challenge to an Orthopaedician. Limb salvage is the goal of treatment and this entails sacrifice of the common peroneal nerve as well as the anterior tibial artery. Also the loss of lateral collateral ligament and biceps attachment leads to unavoidable knee instability which requires special reconstructive procedures.Methods From 2002 to 2008 eight patients with non metastatic osteosarcoma of fibular head were treated in our institution with Malawer type II resection. Special attention was paid to reconstructing lateral collateral ligament and to post operative knee stability. All the patients completed the standard course of neoadjuvant and post operative chemotherapy.ResultsNegative margins were achieved in all the 8 patients and consequently none required secondary resection or amputation. Seven of these patients are still alive without evidence of any disease. . All these patients have full ROM of the knee and no problems in carrying out their activities of daily living. None of the surviving patients has any evidence of local recurrence at the last follow up visit.DiscussionOur results indicate that the sacrifice of common peroneal nerve ensures a wide margin of resection which in turn correlates with long term survival. Also our technique of reconstruction of lateral knee structures has produced good functional outcome without significant postoperative knee instability. 630
Poster Topic: Tumours Abstract number: 24461 PATIENT SURVIVAL AND COMPLICATIONS AFTER SURGERY FOR SKELETAL METASTASES FROM LUNG CANCER Rikard WEDIN, Rüdiger WEISS Department of Orthopaedic Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm (SWEDEN) Background: The benefit of palliative Orthopaedic surgery for lung cancer patients with bone metastases and a short expected survival is often difficult to predict. The aim of the study was to assess survival rates and to identify predictors of survival after surgery for skeletal metastases. Methods:This study was based on data recorded in the Karolinska Skeletal Metastasis Register. We extracted all lung cancer patients who had surgery due to skeletal metastases 1987 to 2006. Kaplan-Meier and Cox-regression analysis was used calculate cumulative survival and predictors of survival.Results:We identified 98 lung cancer patients treated surgically for skeletal metastases. The median survival time after surgery was 2.6 months. The cumulative 12 months survival after surgery was 13%. There was a statistically significant difference between the median survival after spinal surgery (1.8 months) compared with extremity surgery (3.5 months).Metastatic lesions in the vertebra (OR 1.8, p=0.049), complete pathologic fractures (OR 1.9, p=0.043), low hemoglobin levels (OR 2.8, p=0.004) and the absence of postoperative radiotherapy (OR 1.9, p=0.04) were identified as independent negative predictors of survival.The reoperation rate was 15% and complications treated non-surgically were seen in 5% of the patients.Conclusions:Bone metastases and their subsequent surgical treatment in lung cancer patients are associated with considerable negative effects on both morbidity and mortality. The information in this study helps to set appropriate expectations for these patients, their families and surgeons. 631
- Page 579 and 580: Poster Topic: Trauma - Knee Abstrac
- Page 581 and 582: Poster Topic: Trauma - Shoulder Abs
- Page 583 and 584: Poster Topic: Trauma - Shoulder Abs
- Page 585 and 586: Poster Topic: Trauma - Shoulder Abs
- Page 587 and 588: Poster Topic: Trauma - Shoulder Abs
- Page 589 and 590: Poster Topic: Trauma - Spine Abstra
- Page 591 and 592: Poster Topic: Trauma - Spine Abstra
- Page 593 and 594: Poster Topic: Trauma - Systemic Abs
- Page 595 and 596: Poster Topic: Trauma - Systemic Abs
- Page 597 and 598: Poster Topic: Trauma - Systemic Abs
- Page 599 and 600: Poster Topic: Trauma - Systemic Abs
- Page 601 and 602: Poster Topic: Trauma - Systemic Abs
- Page 603 and 604: Poster Topic: Trauma - Systemic Abs
- Page 605 and 606: Poster Topic: Trauma - Tibia/Fibula
- Page 607 and 608: Poster Topic: Trauma - Tibia/Fibula
- Page 609 and 610: Poster Topic: Trauma - Tibia/Fibula
- Page 611 and 612: Poster Topic: Trauma - Tibia/Fibula
- Page 613 and 614: Poster Topic: Trauma - Tibia/Fibula
- Page 615 and 616: Poster Topic: Trauma - Tibia/Fibula
- Page 617 and 618: Poster Topic: Tumours Abstract numb
- Page 619 and 620: Poster Topic: Tumours Abstract numb
- Page 621 and 622: Poster Topic: Tumours Abstract numb
- Page 623 and 624: Poster Topic: Tumours Abstract numb
- Page 625 and 626: Poster Topic: Tumours Abstract numb
- Page 627 and 628: Poster Topic: Tumours Abstract numb
- Page 629: Poster Topic: Tumours Abstract numb
- Page 633 and 634: Poster Topic: Tumours Abstract numb
- Page 635 and 636: Poster Topic: Tumours Abstract numb
- Page 637 and 638: Poster Topic: Tumours Abstract numb
- Page 639 and 640: Poster Topic: Tumours Abstract numb
- Page 641 and 642: Poster Topic: Tumours Abstract numb
- Page 643 and 644: Poster Topic: Tumours Abstract numb
- Page 645 and 646: Poster Topic: Tumours Abstract numb
- Page 647 and 648: Poster Topic: Tumours Abstract numb
- Page 649 and 650: Poster Topic: Tumours Abstract numb
- Page 651 and 652: Poster Topic: Tumours Abstract numb
- Page 653 and 654: Poster Topic: Tumours Abstract numb
- Page 655 and 656: Poster Topic: Tumours Abstract numb
- Page 657 and 658: Poster Topic: Tumours Abstract numb
- Page 659 and 660: Poster Topic: Tumours Abstract numb
- Page 661 and 662: Poster Topic: Tumours Abstract numb
- Page 663 and 664: Poster Topic: Tumours Abstract numb
Poster<br />
Topic: Tumours<br />
Abstract number: 24461<br />
PATIENT SURVIVAL AND COMPLICATIONS AFTER SURGERY FOR SKELETAL<br />
METASTASES FROM LUNG CANCER<br />
Rikard WEDIN, Rüdiger WEISS<br />
Department of Orthopaedic Surgery, Karolinska University Hospital, Karolinska<br />
Institutet, Stockholm (SWEDEN)<br />
Background: The benefit of palliative Orthopaedic surgery for lung cancer patients<br />
with bone metastases and a short expected survival is often difficult to predict. The<br />
aim of the study was to assess survival rates and to identify predictors of survival<br />
after surgery for skeletal metastases. Methods:This study was based on data<br />
recorded in the Karolinska Skeletal Metastasis Register. We extracted all lung cancer<br />
patients who had surgery due to skeletal metastases 1987 to 2006. Kaplan-Meier<br />
and Cox-regression analysis was used calculate cumulative survival and predictors<br />
of survival.Results:We identified 98 lung cancer patients treated surgically for skeletal<br />
metastases. The median survival time after surgery was 2.6 months. The cumulative<br />
12 months survival after surgery was 13%. There was a statistically significant<br />
difference between the median survival after spinal surgery (1.8 months) compared<br />
with extremity surgery (3.5 months).Metastatic lesions in the vertebra (OR 1.8,<br />
p=0.049), complete pathologic fractures (OR 1.9, p=0.043), low hemoglobin levels<br />
(OR 2.8, p=0.004) and the absence of postoperative radiotherapy (OR 1.9, p=0.04)<br />
were identified as independent negative predictors of survival.The reoperation rate<br />
was 15% and complications treated non-surgically were seen in 5% of the<br />
patients.Conclusions:Bone metastases and their subsequent surgical treatment in<br />
lung cancer patients are associated with considerable negative effects on both<br />
morbidity and mortality. The information in this study helps to set appropriate<br />
expectations for these patients, their families and surgeons.<br />
631
Change language